Original article
The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes

https://doi.org/10.1046/j.1444-2892.2003.00160.xGet rights and content

Abstract

Background: Diabetes in humans induces chronic complications such as cardiovascular damage, cataracts and retinopathy, nephropathy and polyneuropathy. The most common animal model of human diabetes is streptozotocin (STZ)-induced diabetes in the rat.

Methods: This project assessed cardiovascular, ocular and neuropathic changes over a period of 24 weeks post STZ administration in rats.

Results: STZ-diabetic rats (n = 96) showed stable signs of diabetes (hyperglycaemia, increased water and food intake with no increase in bodyweight): 52% of untreated STZ-diabetic rats (n = 50) survived 24 weeks after STZ administration. STZ-diabetic rats were normotensive with slowly developing systolic and diastolic dysfunction and an increased ventricular stiffness. Ventricular action potential durations were markedly prolonged. STZ-diabetic rats developed stable tactile allodynia. Cataracts developed to presumed blindness at 16 weeks but proliferative retinopathy was not observed even after 24 weeks.

Conclusion: The chronic STZ-diabetic rat mimics many but not all of the chronic complications observed in the diabetic human. The chronic STZ-diabetic rat may be a useful model to test therapeutic approaches for amelioration of chronic diabetic complications in humans.

References (25)

  • T. Valle et al.

    Epidemiology of NIDDM in Europids

  • Cited by (194)

    • Characterization of vaginal immune response to a polypropylene mesh: Diabetic vs. normoglycemic conditions

      2022, Acta Biomaterialia
      Citation Excerpt :

      To mimic the post-menopausal status in women who receive mesh implantations and minimize the impact of estrogen variability, we performed bilateral ovariectomy at the time of mesh implantation. Streptozotocin (STZ) was used to selectively destroy pancreatic β cells, thereby induce diabetes with hyperglycemia as the major attribute [26–29]. We hypothesized that diabetes dysregulates the vaginal immune response to mesh, leading to an increased and prolonged inflammation at the mesh-tissue interface.

    View all citing articles on Scopus

    Presented at the International Society for Heart Research and International Union of Physiological Societies World Congress Satellite Meeting, Models of Cardiovascular Disease, 2–4 September 2001, Brisbane, Australia.

    View full text